XILIO THERAPEUTICS INC

Historical 13F Holders

Symbol: XLO
CUSIP: 98422T209
All holders as of: Q2 2026
Type: Equity
Class: COM

Reported Value, Excluding Options

Total Shares Held, Excluding Options

Total Filers

13D/G Filers

Each filer's latest filing for 98422T209 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Bain Capital Life Sciences Fund II, L.P. 13G/A	10.0%	664,021	13G/A	5/15/2026 Event 3/31/2026
BCLS II Equity Opportunities, LP	10.0%	664,021
Bain Capital Life Sciences Fund II, L.P.	0%	0
BCIP Life Sciences Associates, LP	0%	0
StemPoint Capital LP 13G/A	9.5%	628,866	13G/A	8/14/2026 Event 6/30/2026
StemPoint Capital LP	9.5%	628,866
StemPoint Capital Management GP LLC	9.5%	628,866
Michelle Ross	9.5%	628,866

13F Holders by Quarter

Period	Filers	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	3	41.5 k	$376k	$0
2026 Q2	26	2.76 M	$26.4M	$0
2026 Q1	23	1.97 M	$16.6M	$0